Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis

Punctate Inner Choroidopathy Clinical Trial

Official title:

Long-term Outcome of Punctate Inner Choroidopathy or Multifocal Choroiditis With Active Choroidal Neovascularization Managed With Anti-vascular Endothelial Growth Factor

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03897192
• Other study ID #: 190318
• Status: Completed
• Start date: October 1, 2018
• Est. completion date: March 20, 2019

Study information

• Verified date: March 2019
• Source: Changhua Christian Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

To report the long term prognosis in patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 14
• Est. completion date: March 20, 2019
• Est. primary completion date: January 31, 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 50 Years

Eligibility

Inclusion Criteria:

• Patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).

• Follow up over 4 years.

Exclusion Criteria:

• Patients with punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) without zonal outer retinopathy (ZOR).

Related Conditions & MeSH terms

• Choroidal Neovascularization
• Choroiditis
• Punctate Inner Choroidopathy

Intervention

Drug:
• Bevacizumab
Anti-vascular endothelial growth factor (VEGF)

Locations

Country	Name	City	State
Taiwan	Changhua Christian Hospital	Changhua

Sponsors (1)

Lead Sponsor	Collaborator
Changhua Christian Hospital

Country where clinical trial is conducted

Taiwan, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Wilcoxon Signed-Rank test	A statistical comparison of average of different time point	Baseline, 4 year
Secondary	visual acuity	visual acuity change in logMAR in different time point	Baseline, 6 month, 12 month, 24 month, 36 month, 48 month